Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up.

Authors :: Wanschitz JV
Kaml M
Pfausler B
Helbok R
Wildner S
Widmann G
Sahanic S
Deisenhammer F
Löscher WN
Reindl M
Löffler-Ragg J
Beer R
Source :: Journal of neurology [J Neurol] 2021 Aug; Vol. 268 (8), pp. 2700-2702. Date of Electronic Publication: 2020 Nov 20.
Publication Year :: 2021

Subjects :: Follow-Up Studies
Humans
Rituximab adverse effects
SARS-CoV-2
COVID-19
Myasthenia Gravis complications
Myasthenia Gravis drug therapy

Full Text Access

Tools